US Stock MarketDetailed Quotes

VVOS Vivos Therapeutics

Watchlist
  • 4.9500
  • +0.3400+7.38%
Close Dec 16 16:00 ET
  • 5.1267
  • +0.1767+3.57%
Post 20:01 ET
23.93MMarket Cap-0.99P/E (TTM)

Vivos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vivos Therapeutics Q3 2024 Earnings Date

Currency：USDNov 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
4.18M
3.86M
-320.25K
Miss Est.
+26.64%
+16.93%
-7.66%
EPS
-0.65
-0.40
+0.25
Beat Est.
+62.58%
+77.14%
+38.92%
Analyst Rating
Buy

Nov 30, 2024

Vivos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.100M--
--2024/Q4-- / 3.885M--
Nov 14, 20242024/Q33.860M / 4.180M--
Aug 14, 20242024/Q24.054M / 3.600M--
May 14, 20242024/Q13.419M / 3.500M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.100M--
--2024/Q4-- / 3.885M--
Nov 14, 20242024/Q33.860M / 4.180M--
Aug 14, 20242024/Q24.054M / 3.600M--
May 14, 20242024/Q13.419M / 3.500M--

Unlock Free Earnings Estimates

Vivos Therapeutics Earnings Reports

  • Vivos Therapeutics | 8-K: Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update

    Nov 15 06:00

  • Vivos Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 15 05:22

  • Vivos Therapeutics | 8-K: Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

    Aug 16 00:57

  • Vivos Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 15 04:28

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data